VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $13,662,000 | -22.1% | 76,588 | -3.0% | 2.73% | -14.0% |
| Q2 2015 | $17,547,000 | +5.6% | 78,987 | -5.6% | 3.18% | +1.4% |
| Q1 2015 | $16,620,000 | +36.7% | 83,677 | -1.5% | 3.13% | +30.3% |
| Q4 2014 | $12,161,000 | +7.7% | 84,975 | -1.3% | 2.40% | -1.7% |
| Q3 2014 | $11,294,000 | +8.4% | 86,085 | +4.2% | 2.44% | +5.8% |
| Q2 2014 | $10,416,000 | +4.9% | 82,585 | +9.6% | 2.31% | -1.5% |
| Q1 2014 | $9,934,000 | +13.6% | 75,355 | +1.2% | 2.35% | +9.8% |
| Q4 2013 | $8,745,000 | +16.7% | 74,485 | +3.7% | 2.14% | +0.7% |
| Q3 2013 | $7,496,000 | +23.4% | 71,845 | +1.8% | 2.12% | +17.3% |
| Q2 2013 | $6,073,000 | – | 70,555 | – | 1.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |